Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Have Never Been This Bullish On Apyx Medical Corporation (APYX)

Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock. The S&P 500 Index ETF (SPY) lost 2.6% in the first two months of the second quarter. Ten out of 11 industry groups in the S&P 500 Index lost value in May. The average return of a randomly picked stock in the index was even worse (-3.6%). This means you (or a monkey throwing a dart) have less than an even chance of beating the market by randomly picking a stock. On the other hand, the top 20 most popular S&P 500 stocks among hedge funds not only generated positive returns but also outperformed the index by about 3 percentage points through May 30th. In this article, we will take a look at what hedge funds think about Apyx Medical Corporation (NASDAQ:APYX).

Is Apyx Medical Corporation (NASDAQ:APYX) going to take off soon? The best stock pickers are in an optimistic mood. The number of bullish hedge fund bets inched up by 4 lately. Our calculations also showed that apyx isn’t among the 30 most popular stocks among hedge funds.

Why do we pay any attention at all to hedge fund sentiment? Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 40 percentage points since May 2014 through May 30, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 30.9% through May 30, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Chuck Royce

Let’s analyze the recent hedge fund action surrounding Apyx Medical Corporation (NASDAQ:APYX).

Hedge fund activity in Apyx Medical Corporation (NASDAQ:APYX)

Heading into the second quarter of 2019, a total of 13 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 44% from one quarter earlier. By comparison, 4 hedge funds held shares or bullish call options in APYX a year ago. So, let’s check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

No of Hedge Funds with APYX Positions

The largest stake in Apyx Medical Corporation (NASDAQ:APYX) was held by Archon Capital Management, which reported holding $9.6 million worth of stock at the end of March. It was followed by Royce & Associates with a $4.8 million position. Other investors bullish on the company included Renaissance Technologies, Horizon Asset Management, and Millennium Management.

Now, some big names have jumped into Apyx Medical Corporation (NASDAQ:APYX) headfirst. Archon Capital Management, managed by Constantinos J. Christofilis, assembled the most outsized position in Apyx Medical Corporation (NASDAQ:APYX). Archon Capital Management had $9.6 million invested in the company at the end of the quarter. Chuck Royce’s Royce & Associates also made a $4.8 million investment in the stock during the quarter. The other funds with new positions in the stock are Jim Simons’s Renaissance Technologies, Murray Stahl’s Horizon Asset Management, and Israel Englander’s Millennium Management.

Let’s now review hedge fund activity in other stocks – not necessarily in the same industry as Apyx Medical Corporation (NASDAQ:APYX) but similarly valued. We will take a look at Advanced Emissions Solutions, Inc. (NASDAQ:ADES), Independence Contract Drilling Inc (NYSE:ICD), Del Frisco’s Restaurant Group Inc (NASDAQ:DFRG), and Nemaura Medical Inc. (NASDAQ:NMRD). This group of stocks’ market valuations match APYX’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
ADES 6 36808 0
ICD 13 95880 1
DFRG 14 80979 1
NMRD 1 36 1
Average 8.5 53426 0.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 8.5 hedge funds with bullish positions and the average amount invested in these stocks was $53 million. That figure was $28 million in APYX’s case. Del Frisco’s Restaurant Group Inc (NASDAQ:DFRG) is the most popular stock in this table. On the other hand Nemaura Medical Inc. (NASDAQ:NMRD) is the least popular one with only 1 bullish hedge fund positions. Apyx Medical Corporation (NASDAQ:APYX) is not the most popular stock in this group but hedge fund interest is still above average. Our calculations showed that top 20 most popular stocks among hedge funds returned 6.2% in Q2 through June 19th and outperformed the S&P 500 ETF (SPY) by nearly 3 percentage points. Hedge funds were also right about betting on APYX, though not to the same extent, as the stock returned 5.4% during the same time frame and outperformed the market as well.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...